CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $785.91 million. The enterprise value is $480.15 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 217.70 million shares outstanding. The number of shares has increased by 86.87% in one year.
| Current Share Class | 217.70M |
| Shares Outstanding | 217.70M |
| Shares Change (YoY) | +86.87% |
| Shares Change (QoQ) | +4.47% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 64.03% |
| Float | 189.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.18 |
| Forward PS | 39.17 |
| PB Ratio | 2.58 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.38, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.38 |
| Quick Ratio | 10.21 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.29% and return on invested capital (ROIC) is -21.72%.
| Return on Equity (ROE) | -34.29% |
| Return on Assets (ROA) | -16.89% |
| Return on Invested Capital (ROIC) | -21.72% |
| Return on Capital Employed (ROCE) | -19.01% |
| Weighted Average Cost of Capital (WACC) | 16.14% |
| Revenue Per Employee | $515,101 |
| Profits Per Employee | -$900,623 |
| Employee Count | 69 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $235,000 in taxes.
| Income Tax | 235,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.68% in the last 52 weeks. The beta is 2.17, so CTMX's price volatility has been higher than the market average.
| Beta (5Y) | 2.17 |
| 52-Week Price Change | +51.68% |
| 50-Day Moving Average | 4.46 |
| 200-Day Moving Average | 3.92 |
| Relative Strength Index (RSI) | 29.92 |
| Average Volume (20 Days) | 3,098,734 |
Short Selling Information
The latest short interest is 29.74 million, so 13.66% of the outstanding shares have been sold short.
| Short Interest | 29.74M |
| Short Previous Month | 27.52M |
| Short % of Shares Out | 13.66% |
| Short % of Float | 15.70% |
| Short Ratio (days to cover) | 6.95 |
Income Statement
In the last 12 months, CTMX had revenue of $35.54 million and -$62.14 million in losses. Loss per share was -$0.39.
| Revenue | 35.54M |
| Gross Profit | 35.54M |
| Operating Income | -61.86M |
| Pretax Income | -58.91M |
| Net Income | -62.14M |
| EBITDA | -60.62M |
| EBIT | -61.86M |
| Loss Per Share | -$0.39 |
Full Income StatementBalance Sheet
The company has $346.71 million in cash and $2.86 million in debt, with a net cash position of $343.85 million or $1.58 per share.
| Cash & Cash Equivalents | 346.71M |
| Total Debt | 2.86M |
| Net Cash | 343.85M |
| Net Cash Per Share | $1.58 |
| Equity (Book Value) | 319.94M |
| Book Value Per Share | 1.47 |
| Working Capital | 319.07M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$80.09 million and capital expenditures -$101,000, giving a free cash flow of -$80.19 million.
| Operating Cash Flow | -80.09M |
| Capital Expenditures | -101,000 |
| Depreciation & Amortization | 1.24M |
| Net Borrowing | n/a |
| Free Cash Flow | -80.19M |
| FCF Per Share | -$0.37 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -174.04% and -166.40%.
| Gross Margin | 100.00% |
| Operating Margin | -174.04% |
| Pretax Margin | -165.74% |
| Profit Margin | -166.40% |
| EBITDA Margin | -170.54% |
| EBIT Margin | -174.04% |
| FCF Margin | n/a |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -86.87% |
| Shareholder Yield | -86.87% |
| Earnings Yield | -7.54% |
| FCF Yield | -9.73% |
Analyst Forecast
The average price target for CTMX is $11.50, which is 218.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.50 |
| Price Target Difference | 218.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 28.45% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
